Pfizer 2nd-Quarter Profit Falls 48 Percent
543424
Pfizer Inc. reaffirmed its full-year guidance Wednesday despite a 48 percent drop in second-quarter profit because of lagging sales of cholesterol drug Lipitor and generic competition for Zoloft and Norvasc.
347146
AstraZeneca reported a 12.5 percent drop in profit and Bristol-Myers Squibb posted a loss, albeit a narrower one.
716268
Bristol-Myers Squibb Co., a major drug maker, reported on Friday that its third-quarter profit fell 16 percent as the company continues to struggle with loss of patent protection
322803
DuPont Co. , the No. 2 U.S.  chemical company, on Tuesday reported lower-than-expected  second-quarter profit due to lower U.S. volumes coupled with  higher energy and raw material costs.
554177
The printer maker said its second-quarter profit declined 16 percent, to $64.2 million, on lower consumer segment sales and higher costs.
350780
The newspaper publisher and television station operator said third-quarter profit fell to $2.5 million as ad revenue slumped.
326217
Bayer unveiled a mixed set of second-quarter results, with operating profit beating analysts' expectations although bottom-line earnings stagnated and the pharmaceuticals division continued to cause headaches for the German maker of Aspirin.
707565
Pfizer Inc  reported a higher-than-expected fourth-quarter profit on Wednesday, helped by lower taxes, a weak dollar and demand for drugs to treat nerve pain, kidney cancer and to help smokers kick the habit.
178771
Transportation giant Bombardier Inc. said Wednesday that its second-quarter profit slid to $23 million from $68 million a year ago, but showed a sharp improvement from the first quarter&#39;s $174 million loss.
176833
The company said that one-time costs and a recall of Easy-Bake Ovens drove its second-quarter profit well below year-ago results.
259614
NEW YORK - Shares of pharmaceutical company Pfizer Inc. fell sharply in early trading after the firm reported an increased risk of heart disease for patients taking its Celebrex painkiller and arthritis drug.
279543
DuPont Co. , the No. 2 U.S. chemical company, on Tuesday reported lower-than-expected second-quarter profit due to lower U.S. volumes coupled with higher energy and raw material costs.
677326
BASEL, Switzerland  - Swiss drugmaker Novartis AG  missed forecasts with a 42 percent drop in fourth-quarter net profit, hit by generic competition and a one-off restructuring charge, sending its shares lower.
334672
NEW YORK : Bristol-Myers Squibb said its third-quarter profit dipped 16 percent from a year ago to 758 million dollars as the pharmaceutical giant boosted research in the face of expiring patents.
275173
NEW YORK -- Pfizer Inc. said Tuesday it will cut its U.S. sales force by 20 percent, or 2,200 people, as part of a cost-cutting program to transform the company into a more nimble organization as it struggles with sluggish sales.
736761
DuPont Co.'s  second-quarter  profit fell as price hikes for its products failed to offset  increases in energy costs, the No. 2 U.S. chemicals maker said  on Tuesday.
468942
Merck & Co. MRK.N on Thursday said  its quarterly profit fell 28 percent due to last month's recall  of its Vioxx arthritis drug, and the company predicted 2004  earnings will fall as much as 11 percent because of the recall.